Fundraising Fox

Global Bridge Capital

Growth equity

Palo Alto · Growth–Late Stage

Fox Verdict
Sign up to see your fit

Investment thesis

Global Bridge Capital positions itself as a technology growth capital firm focused on supporting leading global technology companies in accessing and expanding into the Asia and Greater China markets. Its emphasis is on growth-stage technology businesses seeking cross-border market entry and scale across these regions.

Source: firm website, verified Aug 3, 2026.

Stage
Growth–Late Stage
HQ
Palo Alto, US
Tracked investments
1

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Hardware ×1Healthtech ×1Medical Devices ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Avvio Medicalavviomedical.com✓ verified

Avvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa.

BiotechHardwareHealthtechMedical DevicesSan Francisco, US

Marshall Stoller(Founder (MD))Paul Molloy(Chief Executive Officer & Director)Gregory Johnstone(Executive Officer)Ben Zadik(Executive Officer)Liu Chang(Director)John Garcia(Director)

Co-investorsKairos Venture Investments, Llc

Portfolio news

latest coverage across their companies
Resources | Avvio Medical

Avvio Medical · avviomedical.com · Jun 19, 2025

Frequently asked questions

What stage does Global Bridge Capital invest at?
Global Bridge Capital invests at the Growth, Late Stage stages.
What sectors does Global Bridge Capital focus on?
Global Bridge Capital focuses on Enterprise Software, Sector Agnostic.
Where is Global Bridge Capital located?
Global Bridge Capital is headquartered in Palo Alto, US.

Similar investors

Featured in lists